α-Amylase/α-Glucosidase-IN-14
α-Amylase/α-Glucosidase-IN-14 (compound 6E) is an oral bioactive inhibitor of α-amylase and α-glucosidase, with the IC50s of 45.53 μM and 27.73 μM, respectively[1].
Product Specifications
UNSPSC
12352005
Target
Amylases; Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/α-amylase-α-glucosidase-in-14.html
Smiles
O=C(NC1=CC=C(F)C=C1)CSC(O2)=NN=C2CCN3C4=C(C=CC=C4)C5=C3C=CC=C5
Molecular Formula
C24H19FN4O2S
Molecular Weight
446.50
References & Citations
[1]Shuang Luo, et al. Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation. Eur J Med Chem.2024 Jun 14:275:116600.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680177-500 1x 500 µL
CD50 (ICAM-3) (101-1D2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740270-500 1x 500 µL
Fibronectin (HFN7.1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740029-100 1x 100 µL
Fibronectin (TV-1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682562-500 1x 500 µL
CD63 (Late Endosomes Marker) (rMX-49.129.5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472885-100 1x 100 µL
CD81 / TAPA-1 (C81/2885R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details